Inter-subject variability in Full replicate design [RSABE / ABEL]

posted by MGR  – India, 2021-09-30 07:35 (272 d 09:58 ago) – Posting: # 22605
Views: 1,098

Dear All,

Need help on formula/procedure to find out the Intersubject Variability for a Full replicate design using SAS.

Based on the Program given in the progesterone guideline below:

PROC MIXED
 data=pk;
 CLASSES SEQ SUBJ PER TRT;
 MODEL LAUCT = SEQ PER TRT/ DDFM=SATTERTH;
 RANDOM TRT/TYPE=FA0(2) SUB=SUBJ G;
 REPEATED/GRP=TRT SUB=SUBJ;
 ESTIMATE 'T vs. R' TRT 1 -1/CL ALPHA=0.1;
 ods output Estimates=unsc1;
 title1 'unscaled BE 90% CI - guidance version';
 title2 'AUCt';


As there is no subj(seq) in the random statement, I am not able to calculate the inter-subject variabilities for test and reference treatments. Please help me with this calculation.

But when I use the proc varcomp procedure in SAS, I am able to generate the Variabilities (Inter and Intra) for test and reference treatments. My doubt is that whether it is acceptable by FDA regulatory?

Thanks in Advance,

Regards,
MGR

Complete thread:

UA Flag
Activity
 Admin contact
22,181 posts in 4,647 threads, 1,572 registered users;
online 7 (0 registered, 7 guests [including 1 identified bots]).
Forum time: Wednesday 17:34 CEST (Europe/Vienna)

Nerds don’t just happen to dress informally.
They do it too consistently.
Consciously or not, they dress informally
as a prophylactic measure against stupidity.    Paul Graham

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5